Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Madrigal Pharmaceuticals
Madrigal Pharmaceuticals
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group
3 Things to Watch From the Pharmaceutical Industry's Liver Meeting
Motley Fool
Wed, 10/23/19 - 10:40 am
liver disease
NASH
The Liver Meeting
Assembly Biosciences
CymaBay Therapeutics
Madrigal Pharmaceuticals
NASH drugmaker stocks rebound after dip on FDA guidance
Biopharma Dive
Mon, 06/10/19 - 06:08 pm
NASH
FDA
Madrigal Pharmaceuticals
Viking Therapeutics
Intercept Pharma
Genfit
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
Motley Fool
Wed, 12/12/18 - 09:59 am
TG Therapeutics
Madrigal Pharmaceuticals
Puma Biotechnology
Here's Why Madrigal Pharmaceuticals Fell 39.4% in November
Motley Fool
Sun, 12/9/18 - 03:55 pm
Madrigal Pharmaceuticals
NASH
MGL-3196
Viking Therapeutics
VK2809
The 4 Best Biotech Stocks of 2018 (So Far)
Motley Fool
Sat, 07/14/18 - 01:22 pm
biotech
Arrowhead Research
Endocyte
Arqule
Madrigal Pharmaceuticals
3 Huge Biotech Winners in 2018 (So Far)
Motley Fool
Wed, 07/11/18 - 10:17 am
biotech
Arrowhead Pharmaceuticals
Endocyte
Madrigal Pharmaceuticals
4 Biotech Stocks That Tripled in the First Half of 2018
Motley Fool
Mon, 07/2/18 - 10:17 pm
biotech
biotech stocks
Arrowhead Pharmaceuticals
Arqule
Endocyte
Madrigal Pharmaceuticals
Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives
Yahoo/Benzinga
Sun, 06/24/18 - 09:32 pm
Bluebird Bio
Celgene
LentiGlobin
Madrigal Pharmaceuticals
Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers
Motley Fool
Fri, 06/15/18 - 07:04 pm
NASH
liver disease
Viking Therapeutics
Madrigal Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Gilead Sciences
With Headway in NASH, Madrigal Pharma is Considering Sale
BioSpace
Thu, 06/14/18 - 10:38 pm
Madrigal Pharmaceuticals
M&A
NASH
Madrigal Pharma shares skyrocket 145% on positive results for liver disease therapy
Marketwatch
Sun, 06/3/18 - 10:03 am
Madrigal Pharmaceuticals
NASH
clinical trials
MGL-3196
3 Great Acquisition Targets for Gilead Sciences -- and 1 Iffy Candidate
Motley Fool
Thu, 02/15/18 - 11:08 am
Gilead Sciences
M&A
Editas
Madrigal Pharmaceuticals
CRISPR Therapeutics
Galapagos
Madrigal shares slide despite Phase 2 success
Biopharma Dive
Sat, 02/10/18 - 09:39 am
Madrigal Pharmaceuticals
clinical trials
familial hypercholesterolemia
MGL-3196
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
Motley Fool
Mon, 01/29/18 - 09:17 am
biotech
Bluebird Bio
Madrigal Pharmaceuticals
SAGE Therapeutics
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
M&A
Allergan
Alnylam
Biomarin
Bristol-Myers Squibb
Incyte
Madrigal Pharmaceuticals
Spark Therapeutics
Sucampo
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Mon, 10/2/17 - 09:59 am
biotech
Madrigal Pharmaceuticals
Spectrum Pharmaceuticals
poziotinib
ZX008
Zogenix
3 Biotech Stocks That Skyrocketed Last Week: Can They Go Higher?
Motley Fool
Mon, 09/25/17 - 09:42 am
Madrigal Pharmaceuticals
MGL-3196
Alnylam
Sanofi
Arbutus BioPharma
Synta's marriage with Pennsylvania drugmaker spurred by actual marriage
Bizjournals.com
Fri, 04/15/16 - 08:33 am
Synta Pharmaceuticals
Madrigal Pharmaceuticals
M&A
Pages
« first
‹ previous
1
2